Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Merkel Cell Carcinoma, Stage II”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Early research (Phase 1)Active Not RecruitingNCT04975152
What this trial is testing

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 36
Testing effectiveness (Phase 2)Looking for participantsNCT07302347
What this trial is testing

Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

Who this might be right for
Malignant NeoplasmCarcinoma, Merkel CellLymphoma
Merck Sharp & Dohme LLC 20
Testing effectiveness (Phase 2)Study completedNCT00003549
What this trial is testing

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

Who this might be right for
Neuroendocrine Carcinoma of the Skin
SWOG Cancer Research Network 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07472322
What this trial is testing

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Who this might be right for
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IIIMerkel Cell Carcinoma, Stage IV
University of Wisconsin, Madison 31
Testing effectiveness (Phase 2)Study completedNCT02155647
What this trial is testing

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Who this might be right for
Carcinoma, Merkel Cell
EMD Serono Research & Development Institute, Inc. 204
Testing effectiveness (Phase 2)Looking for participantsNCT02479698
What this trial is testing

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Who this might be right for
Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency Virus+5 more
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Testing effectiveness (Phase 2)Study completedNCT00004922
What this trial is testing

Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Carcinoma of Unknown PrimaryNeuroendocrine CarcinomaNeuroendocrine Carcinoma of the Skin
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02054884
What this trial is testing

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell Carcinoma
Philogen S.p.A. 13
Testing effectiveness (Phase 2)Study completedNCT02819843
What this trial is testing

T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors

Who this might be right for
MelanomaMerkel Cell CarcinomaOther Solid Tumors
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 60
Testing effectiveness (Phase 2)UnknownNCT05329792
What this trial is testing

L19IL2/L19TNF in Skin Cancer Patients

Who this might be right for
BCC - Basal Cell CarcinomaSCC - Squamous Cell CarcinomaMerkel Cell Carcinoma+4 more
Philogen S.p.A. 70
Testing effectiveness (Phase 2)Study completedNCT02267603
What this trial is testing

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Who this might be right for
Recurrent Merkel Cell CarcinomaStage III Merkel Cell Carcinoma AJCC v7Stage IIIA Merkel Cell Carcinoma AJCC v7+2 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Large-scale testing (Phase 3)Active Not RecruitingNCT03712605
What this trial is testing

Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial

Who this might be right for
Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
National Cancer Institute (NCI) 280
Testing effectiveness (Phase 2)Study completedNCT02351128
What this trial is testing

Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues

Who this might be right for
Carcinoma, Merkel Cell
University Hospital, Grenoble 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04261855
What this trial is testing

Targeted Therapy and Avelumab in Merkel Cell Carcinoma

Who this might be right for
Metastatic Merkel Cell Carcinoma
Melanoma and Skin Cancer Trials Limited 19
Testing effectiveness (Phase 2)Study completedNCT01440816
What this trial is testing

IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer

Who this might be right for
Merkel Cell Carcinoma
OncoSec Medical Incorporated 15
Load More Results